Skip to main content
Samuel So, MD, General Surgery, Stanford, CA, Stanford Health Care

SamuelKai SumSoMD

General Surgery Stanford, CA

Surgical Oncology (Other than Breast)

Professor, Surgery, Stanford University Medical Center

Dr. So is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. So's full profile

Already have an account?

  • Office

    Stanford Cancer Center
    875 Blake Wilbur Drive
    Stanford, CA 94305
    Phone+1 650-498-6000
    Fax+1 650-736-1048
  • Is this information wrong?

Education & Training

  • University of Minnesota
    University of MinnesotaResidency, Surgery, 1980 - 1987
  • University of Hong Kong Faculty of Medicine
    University of Hong Kong Faculty of MedicineClass of 1978

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1992 - 2024
  • MN State Medical License
    MN State Medical License 1988 - 1996

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Fellow American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Updated Immunization and Screening Recommendations Aim To Eradicate Hepatitis B
    Updated Immunization and Screening Recommendations Aim To Eradicate Hepatitis BMay 9th, 2023
  • Bill, Supported by Stanford Doctor, Guards Against Hepatitis
    Bill, Supported by Stanford Doctor, Guards Against HepatitisNovember 19th, 2021
  • Globe-Trotting Decision Scientist Seeks Solutions to Hepatitis B
    Globe-Trotting Decision Scientist Seeks Solutions to Hepatitis BOctober 2nd, 2018

Grant Support

  • Cd07-005, Translating Research Into The Jade Ribbon CampaignNational Center For Hiv, Viral Hepatitis, Stds And Tb Prevention2007–2009
  • Development Of Glypican-3 As A Biomarker For Hepatocellular CarcinomaNational Cancer Institute2007–2008

Professional Memberships

Hospital Affiliations